Source: Health Products Regulatory Authority (IE) Revision Year: 2017 Publisher: Almirall Hermal GmbH, Scholtzstraße 3, D-21465 Reinbek, Germany Phone: +49 40 727 04 0 Fax: +49 40 72 704 329 E-mail: info@almirall.de
Monovo 1mg/g Cream.
| Pharmaceutical Form |
|---|
|
Cream. A white cream. |
One gram of cream contains 1 mg of mometasone furoate (0.1% mometasone furoate).
Excipients with known effect: 72.00 mg of cetostearyl alcohol (type A), emulsifying; 10.00 mg of cetyl alcohol and 13 microgram of butylated hydroxytoluene /1 gram cream.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mometasone |
Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade. |
| List of Excipients |
|---|
|
Purified water |
The cream is filled in PE/aluminium laminate tubes fitted with a white polypropylene screw cap in a cardboard carton.
Carton of 1 tube.
Tubes with 10g, 15g, 20g, 25g, 30g, 35g, 50g, 60g, 70g, 90g and 100g of cream.
Not all pack sizes may be marketed.
Almirall Hermal GmbH, Scholtzstraße 3, D-21465 Reinbek, Germany
Phone: +49 40 727 04 0
Fax: +49 40 72 704 329
E-mail: info@almirall.de
PA 1548/002/001
Date of first authorisation: 18th November 2011
Date of last renewal: 10th March 2016
| Drug | Countries | |
|---|---|---|
| MONOVO | Austria, Germany, Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
